Related Experiment Video
Updated: Jul 17, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
The future of drug safety
1Medicines and Healthcare products Regulatory Agency, London, UK. Alasdair.Breckenridge@mhra.gsi.gov.uk
Abstract:
To provide a European perspective, I was invited to sit on the Institute of Medicine (IOM) committee that was charged with assessing the current system for evaluating and ensuring postmarketing drug safety in the United States. My colleagues on the committee came from a variety of professional backgrounds (health care, epidemiology, law, and economics), and the committee was managed by an experienced IOM staff member.
Related Concept Videos
Drug Regulation
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Control Governance: Regulatory Bodies and Their Impact
Pharmaceutical Poisoning: Potential Scenarios
Drug Discovery: Overview
Drug Product Stability